Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

F1 is getting a makeover at more than 200 miles per hour, with next season set to feature new teams, a new race and entirely new cars. The 2025 Formula 1 season is in the books, but F1 cars will be ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Lando Norris has become Formula 1 world champion for the first time after finishing third in the Abu Dhabi Grand Prix. The 26-year-old becomes Britain's 11th F1 world champion and is the first McLaren ...

The U.S. is in the grips of a botulism outbreak tied to a premium infant formula brand. Dozens of babies have been affected as of November 19. All the reported cases of the paralyzing bacterial ...

ByHeart, a manufacturer of organic baby formula, recalled all of its products sold nationwide Tuesday, days after some batches were recalled in an expanding outbreak of infant botulism. At least 15 ...

ByHeart, a next-generation baby nutrition company, has announced a voluntary recall of some batches of its powdered infant formula after federal authorities linked the product to an infant botulism ...

Formula E officially revealed its next electric racing car today. At first glance, the Gen4 machine looks similar to machinery of seasons past, but looks are deceiving—it’s “so much more menacing,” ...

Salt Lake City, Utah, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announced that its Board ...

Formula 1 has entered into a new five-year media rights deal with Apple that will bring all F1 races to Apple TV for viewers in the United States beginning in 2026, it was announced on Friday, Oct. 17 ...